乳腺癌
癌症
肿瘤科
雌激素受体
免疫组织化学
内科学
CA15-3号
雌激素
小RNA
医学
疾病
癌症研究
生物
基因
遗传学
作者
Erasmo Orrantia‐Borunda,Patricia Anchondo-Nuñez,Lucero Evelia Acuña-Aguilar,Francisco Octavio Gómez-Valles,Claudia A. Ramírez-Valdespino
出处
期刊:Exon Publications eBooks
[Exon Publications]
日期:2022-08-04
卷期号:: 31-42
被引量:69
标识
DOI:10.36255/exon-publications-breast-cancer-subtypes
摘要
Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR) and human epidermal growth factor (HER2). Accordingly, the following four subtypes of breast cancer are widely recognized: luminal A, luminal B, HER2-positive, and triple negative. With the recent advances in cancer research, and an increased molecular understanding of breast cancer, the current clinical model for classification of breast cancer may be benefit from the addition of several molecular markers such as miRNAs (let-7, miR-155, miR-150, miR-153) and mutations (p53, BRCA 1 and 2 genes). This chapter provides an overview of the characteristics of these four subtypes of breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI